FindTrial
Sign In

A Phase 2b study of M512101 in acne vulgaris for 12weeks

A Phase 2b study of M512101 in acne vulgaris for 12weeks

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221363
Enrollment
Unknown
Registered
2011-01-25
Start date
2011-01-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris

Interventions

investigational material(s) Generic name etc : M512101 INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational mater

Sponsors

Maruho Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with acne vulgaris 2. Outpatient

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The percent reduction in inflammatory lesion counts.—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026